On Thursday, Huntsman Corporation (NYSE:HUN)’s shares declined -0.36% to $23.28.
Huntsman Corporation (HUN) declared that Monte Edlund will succeed Stu Monteith as president of Huntsman’s Performance Products division (HPP), effective July 1.
Most recently vice president for the Americas region in Huntsman’s Advanced Materials division, Edlund joined Huntsman with the acquisition of the Rexene Corporation and has been a senior leader with the company since 1997, when he was designated vice president-polymers. Prior to his role in Advanced Materials, Edlund served as vice president of global specialty textiles for Huntsman’s Textile Effects division based in Singapore.
After more than 35 years’ experience in the chemical industry, 21 of them with Huntsman, Monteith elected to retire as of August 31. He joined Huntsman in 1994 and served as the division’s vice president for global markets and business development before being named Performance Products division president in 2011.
Huntsman Corporation, together with its auxiliaries, manufactures and sells differentiated organic and inorganic chemical products worldwide. The company operates in five segments: Polyurethanes, Performance Products, Advanced Materials, Textile Effects, and Pigments and Additives.
salesforce.com, inc. (NYSE:CRM)’s shares dropped -1.71% to $72.21.
salesforce.com, inc. (CRM) declared that for the first time it has been named to the Fortune 500 list of the largest U.S. companies, ranked by Fortune Magazine. Salesforce is the first enterprise cloud computing company to reach a $6 billion annual revenue run rate and is the fastest growing top 10 software company.
The Salesforce Customer Success Platform
The Salesforce Customer Success Platform brings together cloud apps for sales, service, marketing, community, and now analytics, all on the Salesforce1 Platform. It provides both a system-of-record and a system-of-engagement for companies of every size and industry. Companies can grow sales faster, deliver customer service everywhere, create 1:1 customer journeys, engage with customers in vibrant communities, deliver analytics for every business user and build mobile apps, all from a single trusted platform built for customer success.
salesforce.com, inc. provides enterprise cloud computing solutions, with a focus on customer relationship administration to various businesses and industries worldwide. The company offers enterprise cloud computing apps and platform services, counting Sales Cloud for sales force automation, which enables companies to store data, access accurate customer and prospect information, track leads and progress, forecast opportunities, and collaborate around any sale on desktop and mobile devices; Service Cloud that enables companies to connect address customers service and support needs; and Marketing Cloud, which enables companies to map customer journeys to digital marketing interactions through email, mobile, social, Web, and connected products.
At the end of Thursday’s trade, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)‘s shares surged 0.95% to $4.27.
Arena Pharmaceuticals, Inc. (ARNA) declared that the following poster regarding lorcaserin HCl will be presented at American Diabetes Association’s 75th Scientific Sessions taking place June 5-9, 2015, in Boston, Massachusetts:
This post-hoc analysis evaluated the impact of sulfonylurea use on weight loss and glycemic parameters achieved with lorcaserin in patients with type 2 diabetes mellitus over 52 weeks.
Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight administration in adults. It is also developing a portfolio of programs in various therapeutic areas, counting cardiovascular, central nervous system, and metabolic diseases. Its products under development comprise Ralinepag, an agonist of the prostacyclin receptor intended for the treatment of vascular diseases, counting potentially pulmonary arterial hypertension that is in Phase II clinical trials.
Catamaran Corp (USA) (NASDAQ:CTRX), ended its Thursday’s trading session with 0.69% gain, and closed at $60.25.
Catamaran Corp (USA) (CTRX) the Company’s shareholders did not ratify an amendment (the “Advance Notice Bylaw Amendment”) to the Company’s amended and restated bylaws (the “Bylaws”) to add certain advance notice and other requirements for shareholders to propose director nominations or other business for shareholder meetings. The Advance Notice Bylaw Amendment became effective upon its approval by the Company’s board of directors on October 30, 2014. However, following the provisions of the Yukon Business Corporations Act, the Advance Notice Bylaw Amendment ceased to be effective upon the failure to obtain shareholder ratification at the Meeting. The further amended and restated bylaws, effective as of May 12, 2015, reflecting the removal of Sections 3.7 and 3.8 containing the Advance Notice Bylaw Amendment, are filed as Exhibit 3.1 hereto and incorporated by reference herein.
Catamaran Corporation provides pharmacy benefit administration (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits administration industry in North America. The company operates in two segments, PBM and HCIT. The PBM services comprise electronic point-of-sale pharmacy claims administration, retail pharmacy network administration, mail and specialty pharmacy claims administration, Medicare Part D services, benefit design consultation, preferred drug administration programs, drug review and analysis, consulting services, data access, and reporting and information analysis. It owns and operates a network of mail and specialty pharmacies.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
